Materialise GAAP EPS of €0.03, revenue of €66.28M; reaffirms FY26 outlook

* Materialise press release [https://seekingalpha.com/pr/20504729-materialise-reports-first-quarter-2026-results] (MTLS [https://seekingalpha.com/symbol/MTLS]): Q1 GAAP EPS of €0.03.
* Revenue of €66.28M (-0.2% Y/Y).
* Adjusted EBIT increased to €2,470k for the first quarter of 2026 from €646k or the first quarter of 2025.
* Driven by recurring positive free cash flow, our net cash position increased by €2,021k over the quarter to €72,826k, while €2,308k was invested in share buybacks, underscoring strong cash generation.
* "We reaffirm our full‑year revenue guidance for fiscal year 2026 in the range of 273,000 to 283,000 kEUR. In addition, we are maintaining our Adjusted EBIT guidance for fiscal year 2026 of 10,000 to 12,000 kEUR, reflecting our continued focus on execution discipline, cost management, and capital allocation.”

MORE ON MATERIALISE

* Materialise: The Medical Segment Alone Makes This A Buy [https://seekingalpha.com/article/4895999-materialise-the-medical-segment-alone-makes-this-a-buy]
* Materialise: Medical And Software-Led Rebound [https://seekingalpha.com/article/4873923-materialise-medical-and-software-led-rebound]
* Materialise NV 2025 Q4 - Results - Earnings Call Presentation [https://seekingalpha.com/article/4872918-materialise-nv-2025-q4-results-earnings-call-presentation]
* Materialise Q1 2026 Earnings Preview [https://seekingalpha.com/news/4587068-materialise-q1-2026-earnings-preview]
* Materialise outlines €273M–€283M 2026 revenue target as medical segment maintains double-digit growth [https://seekingalpha.com/news/4554357-materialise-outlines-273m-283m-2026-revenue-target-as-medical-segment-maintains-double-digit]